THBD and COVID-19: Plasma from patients with severe or moderate COVID-19 induced significant upregulation of genes encoding tissue factor, E selectin, and Angpt-2 and concurrently decreased the expression of antithrombotic genes encoding endothelial protein C receptor (EPCR), TFPI, and thrombomodulin (Figure 1).